College of Engineering and daggerCollege of Nursing, University of Cincinnati, Cincinnati, OH, USA.
Spine (Phila Pa 1976). 2010 Jan 1;35(1):124-9. doi: 10.1097/BRS.0b013e3181c46c3a.
Prospective analysis of patients fused with freeze-dried corticancellous allograft, local bone graft, and recombinant human bone morphogenetic protein (rhBMP-2) (Infuse) studied for a minimum follow-up of 24 months.
To assess the fusion rates of the allograft and Infuse using plain radiographs and reconstructed computed tomography (CT) scans. Outcome measures included Oswestry Disability Index, Verbal Rating Pain Scale for back and leg pain, and SF-36 Health Survey as well as complications.
The "gold standard" for arthrodesis of the lumbar spine includes the use of autogenous iliac crest bone graft. Morbidity associated with this harvest is well established. Alternatives to autogenous iliac crest bone graft harvest are being sought both to improve and match arthrodesis rate and secondarily to decrease donor site morbidity.
A prospective consecutive series of 36 patients treated for lumbar acquired spinal stenosis and degenerative disc disease leading to instrumented 1 and 2 level fusions were studied. These patients were arthrodesed with rhBMP-2 and freeze-dried corticancellous allograft and limited amounts of local autogenous bone graft.
Fusion by reconstructed coronal and saggittal CT analysis occurred in 97.2% of the cases. The Oswestry Disability Index, Verbal Rating Pain Scale, and SF-36 Health Survey were statistically improved (P < 0.05) from preoperative to final postoperative values. Complications were limited and unrelated to rhBMP-2 and the absorbable collagen sponge.
rhBMP-2 (Infuse) at a dose of 12 mg/1.5 mg/mL combined with freeze-dried corticancellous allograft and local autogenous spinous process and lamina bone resulted in new bone formation (fusion) as determined by CT scan. In this preliminary study, fusion rates were 97.2% with consistent posterolateral bone formation. Outcomes and complications are consistent with other studies of this type.
对使用冻干皮质松质骨移植物、局部骨移植物和重组人骨形态发生蛋白(rhBMP-2)(Infuse)融合的患者进行前瞻性分析,研究时间至少为 24 个月。
使用普通 X 线片和重建 CT 扫描评估移植物和 Infuse 的融合率。评估指标包括 Oswestry 残疾指数、腰背腿痛的口述评分量表、SF-36 健康调查以及并发症。
腰椎融合术的“金标准”包括使用自体髂嵴骨移植物。这种采集方法相关的发病率是明确的。人们正在寻找替代自体髂嵴骨移植物采集的方法,不仅要提高和匹配融合率,还要降低供体部位的发病率。
对 36 例因腰椎获得性椎管狭窄和退行性椎间盘疾病导致 1 级和 2 级器械融合的患者进行前瞻性连续系列研究。这些患者采用 rhBMP-2 和冻干皮质松质骨移植物以及有限量的局部自体骨移植物进行融合。
通过重建冠状位和矢状位 CT 分析,97.2%的病例发生融合。Oswestry 残疾指数、口述疼痛评分量表和 SF-36 健康调查从术前到最终术后均有统计学改善(P < 0.05)。并发症有限,与 rhBMP-2 和可吸收胶原海绵无关。
剂量为 12mg/1.5mg/mL 的 rhBMP-2(Infuse)与冻干皮质松质骨移植物和局部自体棘突和椎板骨结合,可通过 CT 扫描确定新骨形成(融合)。在这项初步研究中,融合率为 97.2%,具有一致的后外侧骨形成。结果和并发症与其他类似类型的研究一致。